Antibody anti-p16INK4a in cervical cytology

Acta Cytologica

Volumn 53, Issue 3, 2009, Pages 253-262

  Rocha, Alexandre S ^a,b,d   Bozzetti, Mary C ^a,b   Kirschnick, Luciana S ^a,c   Edelweiss, Maria I A ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b Postgraduate Course in Medicine and Medical Sciences   (Brazil)

^c Postgraduate Course in Medicine and Surgery

^d NONE   (Brazil)

Author keywords

Cervical cancer; Cervical smears; Immuno cytochemistry

Indexed keywords

ANTIBODY; CYCLIN DEPENDENT KINASE INHIBITOR 2A; TUMOR MARKER;

ADULT; ARTICLE; CANCER GRADING; COLPOSCOPY; CONTROLLED STUDY; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; MAJOR CLINICAL STUDY; PAPANICOLAOU TEST; PATHOLOGIST; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; CASE CONTROL STUDY; EVALUATION; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; METABOLISM; METHODOLOGY; PRECANCER; PREDICTION AND FORECASTING; REPRODUCIBILITY; UTERINE CERVIX TUMOR; VAGINA SMEAR;

NUCLEOPOLYHEDROVIRUS;

ADULT; CASE-CONTROL STUDIES; CERVICAL INTRAEPITHELIAL NEOPLASIA; COLPOSCOPY; CYCLIN-DEPENDENT KINASE INHIBITOR P16; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; PRECANCEROUS CONDITIONS; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; TUMOR MARKERS, BIOLOGICAL; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 67649815912     PISSN: 00015547     EISSN: 19382650     Source Type: Journal    
DOI: 10.1159/000325304     Document Type: Article

References (48)

1. Sawaya GF: Papanicolaou testing: When does more become less? Am J Med 2005;118:159-160
2. Felix JC, Amezcua C: In vitro adjuncts to the pap smear. Obstet Gynecol Clin North Am 2002;29:685-699, vii
3. Pientong C, Ekalaksananan T, Swadpanich U, Kongyingyoes B, Kritpetcha O, Yuenyao P, Ruckait N: Immunocytochemical detection of p16INK4a protein in scraped cervical cells. Acta Cytol 2003;47:616-623 (Pubitemid 36876715)
4. Nanda K, McCrory DC, Myers ER, Bastian LA, Hasselblad V, Hickey JD, Matchar DB: Accuracy of the Papanicolaou test in screening for and follow-up of cervical cytologic abnormalities: A systematic review. Ann Intern Med 2000;132:810-819 (Pubitemid 30317797)
5. Schneider V, Henry MR, Jimenez-Ayala M, Turnbull LS, Wright TC: Cervical cancer screening, screening errors and reporting. Acta Cytol 2001;45:493-498 (Pubitemid 32674882)
6. Bergeron C, Debaque H, Ayivi J, Amaizo S, Fagnani F: Cervical smear histories of 585 women with biopsy-proven carcinoma in situ. Acta Cytol 1997;41:1676-1680 (Pubitemid 27516292)
7. Sato S, Mikino H, Matsunaga G, Yajima A: False negative rate in mass screening for cervical cancer. Acta Cytol 1998;42:836-837 (Pubitemid 28274819)
8. Cohn DE, Herzog TJ: New innovations in cervical cancer screening. Clin Obstet Gynecol 2001;44:538-549 (Pubitemid 32751775)
9. lenbach-Hellweg G, Trunk MJ, von Knebel DM: Traditional and new molecular methods for early detection of cervical cancer. Arkh Patol 2004;66:35-39
10. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Schnijders PJ, Peto J, Meijer CJ, Muñoz N: Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999;189:12-19 (Pubitemid 29406813)
11. Munoz N: Human papillomavirus and cancer: The epidemiological evidence. J Clin Virol 2000;19:1-5 (Pubitemid 30847618)
12. Schiffman M, Castle PE: Human papillomavirus: Epidemiology and public health. Arch Pathol Lab Med 2003;127:930-934 (Pubitemid 36994850)
13. Bosch FX, Lorincz A, Munoz N, Meijer CJ, Shah KV: The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 2002;55:244-265 (Pubitemid 34293391)
14. Keating JT, Ince T, Crum CP: Surrogate biomarkers of HPV infection in cervical neoplasia screening and diagnosis. Adv Anat Pathol 2001;8:83-92
15. Keating JT, Cviko A, Riethdorf S, Reithdorf L, Quade BJ, Sun D, Duensing S, Sheets EE, Munger K, Crum CP: Ki-67, cyclin E, and p16INK4 are complimentary surrogate biomarkers for human papilloma virus-related cervical neoplasia. Am J Surg Pathol 2001;25:884-891 (Pubitemid 32594981)
16. Stanley MA: Prognostic factors and new therapeutic approaches to cervical cancer. Virus Res 2002;89:241-248 (Pubitemid 35351542)
17. Trunk MJ, Dallenbach-Hellweg G, Ridder R, Petry KU, Ikenberg H, Schneider V, von Knebel Doeberitz M: Morphologic characteristics of p16INK4a-positive cells in cervical cytology samples. Acta Cytol 2004;48:771-782 (Pubitemid 39518255)
18. Lin WM, Ashfaq R, Michalopulos EA, Maitra A, Gazdar AF, Muller CY: Molecular Papanicolaou tests in the twenty-first century: Molecular analyses with fluid-based Papanicolaou technology. Am J Obstet Gynecol 2000;183:39-45 (Pubitemid 30626025)
19. Wang JL, Zheng BY, Li XD, Angstrom T, Lindstrom MS, Wallin KL: Predictive significance of the alterations of p16INK4A, p14ARF, p53, and proliferating cell nuclear antigen expression in the progression of cervical cancer. Clin Cancer Res 2004;10:2407-2414 (Pubitemid 38445700)
20. Murphy N, Ring M, Heffron CC, King B, Ganuguapati UG, Ring M, McGuinness E, Shiels O, O'Leary JJ: p16INK4A, CDC6, and MCM5: Predictive biomarkers in cervical preinvasive neoplasia and cervical cancer. J Clin Pathol 2005;58:525-534 (Pubitemid 40646875)
21. Tringler B, Gup CJ, Singh M, Groshong S, Shrover AL, Heinz DE, Shrover KR: Evaluation of p16INK4a and pRb expression in cervical squamous and glandular neoplasia. Hum Pathol 2004;35:689-696 (Pubitemid 38881079)
22. Wang JL, Zheng BY, Li XD, Nokelainen K, Angström T, Lindström MS, Wallin KL: p16INK4A and p14ARF expression pattern by immunohistochemistry in human papillomavirus-related cervical neoplasia. Mod Pathol 2005;18:629-637 (Pubitemid 40676373)
23. Negri G, Vittadello F, Romano F, Kasal A, Rivasi F, Girlando S, Mian C, Egarter-Vigl E: p16INK4a expression and progression risk of low-grade intraepithelial neoplasia of the cervix uteri. Virchows Arch 2004;445:616-620 (Pubitemid 40104537)
24. Murphy N, Heffron CC, King B, Ganuguapati UG, Ring M, McGuinness E, Shiels O, O'Leary JJ: p16INK4A positivity in benign, premalignant and malignant cervical glandular lesions: A potential diagnostic problem. Virchows Arch 2004;445:610-615 (Pubitemid 40104536)
25. Nieh S, Chen SF, Chu TY, Lai HC, Fu E: Expression of p16INK4A in Pap smears containing atypical glandular cells from the uterine cervix. Acta Cytol 2004;48:173-180 (Pubitemid 38381102)
26. Zielinski GD, Snijders PJ, Rozendaal L, Daalmeijer NF, Risse EK, Voorhorst FJ, Jiwa NM, van der Linden HC, de Schipper FA, Runsink AP, Meijer CJ: The presence of high-risk HPV combined with specific p53 and p16INK4a expression patterns points to high-risk HPV as the main causative agent for adenocarcinoma in situ and adenocarcinoma of the cervix. J Pathol 2003;201:535-543 (Pubitemid 38256402)
27. Ishikawa M, Fujii T, Masumoto N, Saito M, Mukai M, Nindl I, Ridder R, Fukuchi T, Kubushiro K, Tsukazaki K, Nozawa S: Correlation of p16INK4A overexpression with human papillomavirus infection in cervical adenocarcinomas. Int J Gynecol Pathol 2003;22:378-385 (Pubitemid 37152989)
28. Negri G, Egarter-Vigl E, Kasal A, Romano F, Haitel A, Mian C: p16INK4a is a useful marker for the diagnosis of adenocarcinoma of the cervix uteri and its precursors: An immunohistochemical study with immunocytochemical correlations. Am J Surg Pathol 2003;27:187-193 (Pubitemid 36152227)
29. Murphy N, Ring M, Killalea AG, Ulhmann V, O'Donovan M, Mulcahy F, Turner M, McGuinness E, Griffin M, Martin C, Sheils O, O'Leary JJ: p16INK4A as a marker for cervical dyskaryosis: CIN and cGIN in cervical biopsies and ThinPrep smears. J Clin Pathol 2003;56:56-63 (Pubitemid 36132476)
30. Agoff SN, Lin P, Morihara J, Mao C, Kiviat NB, Koutsky LA: p16INK4a expression correlates with degree of cervical neoplasia: A comparison with Ki-67 expression and detection of high-risk HPV types. Mod Pathol 2003;16:665-673 (Pubitemid 36871499)
31. Klaes R, Benner A, Friedrich T, Ridder R, Herrington S, Jenkins D, Kurman RJ, Schmidt D, Stoler M, von Knebel Doeberitz M: p16INK4a immunohistochemistry improves interobserver agreement in the diagnosis of cervical intraepithelial neoplasia. Am J Surg Pathol 2002;26:1389-1399 (Pubitemid 35239415)
32. Saqi A, Pasha TL, McGrath CM, Yu GH, Zhang P, Gupta P: Overexpression of p16INK4A in liquid-based specimens (SurePath) as marker of cervical dysplasia and neoplasia. Diagn Cytopathol 2002;27:365-370 (Pubitemid 35424172)
33. Bibbo M, DeCecco J, Kovatich AJ: p16INK4A as an adjunct test in liquid-based cytology. Anal Quant Cytol Histol 2003;25:8-11 (Pubitemid 36231904)
34. Pientong C, Ekalaksananan T, Kongyingyoes B, Kritpetcharat O, Swadpanich U, Pengsa P, Yuenyao P: Immunocytochemical staining of p16INK4a protein from conventional Pap test and its association with human papillomavirus infection. Diagn Cytopathol 2004;31:235-242 (Pubitemid 39314818)
35. Ichinose H: p16INK4a IHC in the diagnosis of cervical CIN. Am J Surg Pathol 2003;27:1284
36. Klaes R, Friedrich T, Spitkovsky D, Ridder R, Rudy W, Petry U, Dallenbach-Hellweg G, Schmidt D, von Knebel Doesbertiz M: Overexpression of p16INK4A as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri. Int J Cancer 2001;92:276-284 (Pubitemid 32225381)
37. Internet communication: Prefeitura Municipal de Porto Alegre, Bairros Oficiais, Secretaria do Planejamento Municipal, Porto Alegre, RS, Brasil, October 7, 2004
38. Luzzatto R, Boon ME: Contribution of the endocervical Cytobrush sample to the diagnosis of cervical lesions. Acta Cytol 1996;40:1143-1147 (Pubitemid 26424465)
39. Dyanov HM, Dzitoeva SG: Method for attachment of microscopic preparations on glass for in situ hybridization, PRINS and in situ PCR studies. Biotechniques 1995;18:822-824, 826
40. Taylor S, Smith S, Windle B, Guiseppi-Elie A: Impact of surface chemistry and blocking strategies on DNA microarrays. Nucleic Acids Res 2003;31:e87
41. Solomon D, Davey D, Kurman R, Moriarty A, O'Connor D, Prey M, Raab S, Sherman M, Wilbur D, Wright T Jr, Young N, Forum Group Members, Bethesda 2001 Workshop: The 2001 Bethesda System: Terminology for reporting results of cervical cytology. JAMA 2002;287:2114-2119
42. Wright TC Jr, Cox JT, Massad LS, Twiggs LB, Wilkinson EJ: 2001 Consensus guidelines for the management of women with cervical cytological abnormalities. JAMA 2002;287:2120-2129 (Pubitemid 34437347)
43. Wright TC Jr, Cox JT, Massad LS, Carlson J, Twiggs LB, Wilkinson EJ: 2001 consensus guidelines for the management of women with cervical intraepithelial neoplasia. Am J Obstet Gynecol 2003;189:295-304
44. Crum CP: Symposium. Part 1: Should the Bethesda System terminology be used in diagnostic surgical pathology? Point. Int J Gynecol Pathol 2003;22:5-12 (Pubitemid 36014268)
45. Bibbo M, Klump WJ, DeCecco J, Kovatich AJ: Procedure for immunocytochemical detection of P16INK4A antigen in thin-layer, liquid-based specimens. Acta Cytol 2002;46:25-29 (Pubitemid 34111420)
46. Sahebali S, Depuydt CE, Segers K, Moeneclaey LM, Vereecken AJ, Van Marck E, Bogers JJ: p16INK4a as an adjunct marker in liquid-based cervical cytology. Int J Cancer 2004;108:871-876 (Pubitemid 38112616)
47. Negri G, Moretto G, Menia E, Vittadello F, Kasal A, Mian C, Egarter-Vigl E: Immunocytochemistry of p16INK4a in liquid-based cervicovaginal specimens with modified Papanicolaou counterstaining. J Clin Pathol 2006;59:827-830 (Pubitemid 44211743)
48. American Association of Clinical Endocrinologists: Medical guidelines for clinical practice for the diagnosis and treatment of menopause. Endocr Pract 2006;12:315-337